When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio) in optimization of cardiac resynchronization therapy, and how to measure and maximize it. by Pabari, PA et al.
When is an optimization not an optimization? Evaluation
of clinical implications of information content (signal-to-noise
ratio) in optimization of cardiac resynchronization therapy,
and how to measure and maximize it
Punam A. Pabari • Keith Willson • Berthold Stegemann •
Irene E. van Geldorp • Andreas Kyriacou • Michela Moraldo •
Jamil Mayet • Alun D. Hughes • Darrel P. Francis
Published online: 26 November 2010
 The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract Impact of variability in the measured parameter
is rarely considered in designing clinical protocols for
optimization of atrioventricular (AV) or interventricular
(VV) delay of cardiac resynchronization therapy (CRT). In
this article, we approach this question quantitatively using
mathematical simulation in which the true optimum is
known and examine practical implications using some real
measurements. We calculated the performance of any
optimization process that selects the pacing setting which
maximizes an underlying signal, such as flow or pressure,
in the presence of overlying random variability (noise). If
signal and noise are of equal size, for a 5-choice optimi-
zation (60, 100, 140, 180, 220 ms), replicate AV delay
optima are rarely identical but rather scattered with a
standard deviation of 45 ms. This scatter was overwhelm-
ingly determined (q = -0.975, P \ 0.001) by Information
Content, Signal
SignalþNoise, an expression of signal-to-noise ratio.
Averaging multiple replicates improves information con-
tent. In real clinical data, at resting, heart rate information
content is often only 0.2–0.3; elevated pacing rates can
raise information content above 0.5. Low information
content (e.g. \0.5) causes gross overestimation of optimi-
zation-induced increment in VTI, high false-positive
appearance of change in optimum between visits and very
wide confidence intervals of individual patient optimum.
AV and VV optimization by selecting the setting showing
maximum cardiac function can only be accurate if infor-
mation content is high. Simple steps to reduce noise such
as averaging multiple replicates, or to increase signal such
as increasing heart rate, can improve information content,
and therefore viability, of any optimization process.
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Background
After implantation of a resynchronization device (biven-
tricular pacemaker or defibrillator) not all patients undergo
optimization even though guidelines recommend that AV
and VV delay should be optimized, and even though
clinical trials have only demonstrated survival benefit of
individually optimized CRT. Are clinicians right to cut
corners from the trial-validated, guideline-mandated pro-
cess? To answer this, the basic science of optimization
needs to be examined.
For optimization of atrioventricular (AV) delay, com-
monly a range of AV settings is tested, whilst monitoring a
marker of cardiac function such as echocardiographic
velocity–time integral [1, 2] (VTI, a surrogate of stroke
volume [3]) or left ventricular dP/dt [4, 5]. The pacemaker
setting that gives the best cardiac function is then defined
as the optimum. A similar process can also be carried out
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for the delay between activation of left and right ventric-
ular leads (VV delay).
However, every measurement has uncertainties, which
might conceal the true optimum. This uncertainty in our
measurement of VTI (or of any other marker for moni-
toring cardiac function [6, 7]) arises from numerous factors
including natural biological variability [8]. Therefore,
repeating the ‘‘optimization protocol’’ often provides dif-
ferent optima, as shown in Fig. 1.
There are several clinically important questions. First, if
the optimum is not necessarily the ‘true’ underlying opti-
mum, can we at least express its precision, for example, as
a 95% confidence interval?
Second, can we trust the measured increase in VTI as a
good estimate of the ‘true’ average underlying increase in
VTI?
Third, if optimizations 6 months later show that many
patients’ optima have changed, would this imply that
patients require more frequent re-optimization? [7, 9]
Finally, how can the precision of the optimization pro-
tocol be maximized?
It would be difficult and contentious to attempt to
answer these questions by doing clinical studies. This is
partly because in clinical practice it is normally assumed
that the apparent optimum is indeed the true optimum (or at
least the nearest of the tested settings to the true optimum).
Persons other than the operator conducting the optimiza-
tion process itself rarely entertain the possibility that
spontaneous variability of the monitored measurement
during the optimization procedure arising from beat-to-beat
variability and inherent measurement uncertainty has
caused the optimum to be misidentified. Confidence
intervals are not reported for individual clinical patients’
optima [1, 2, 4, 10].
In this study, therefore, we created mathematical simu-
lation having properties exactly like real-life studies, but
in which we could truly know the underlying optimum,
despite the presence of overlying noise. To understand the
realistic balance between underlying optima and overlying
noise, we looked at published studies of optimization.
Information content
A convenient way of quantifying in real-life optimizations
the relative contributions of underlying true signal infor-
mation versus overlying random noise (illustrated in
Fig. 2) is using ‘‘information content’’. Signal, in this
context, is the genuine underlying between-setting differ-
ence in VTI, which for computational convenience can be
expressed as a variance (average of the squared deviate
between the underlying value of each setting and the mean
of all settings). Noise, correspondingly, is the unwanted
variability that occurs when measures are repeated at the
same setting. This too can be expressed as a variance
(average of the squared deviate between individual repli-
cate measurements at a setting and the underlying value of
that setting). The advantage of using variances is that their
sum is the total observed variance. The variance observed
over a series of settings can be decomposed into the vari-
ance arising from the genuine between-setting differences
(signal magnitude) and the remainder which is noise vari-
ance. The proportion of the total variance which is signal
can be called ‘‘information content’’.
Information Content ¼ Signal Variance
Signal Variance + Noise Variance
ð1Þ
The reasons to use information content rather than
simply signal-to-noise ratio are three fold. First, the
information content conveniently varies between 0 and 1,
rather than extending to infinity. Second, it is symmetrical:
Fig. 1 An example of clinical data from typical patient undergoing
three separate Doppler optimization processes (#1, #2 and #3) a few
minutes apart, using one heartbeat of velocity–time integral as the
measurement to be maximized. In this patient, the small differences in
velocity–time integral between the three optimization processes are
enough to cause different AV delay settings to be identified as
apparently optimal on the three occasions
278 Heart Fail Rev (2011) 16:277–290
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noise content is 1 minus information content, which makes
it clear that there are two contributors to observed
differences between settings. Third, it is numerically
identical to the intraclass correlation coefficient, a simple
index of reproducibility used in biological research.
Published data
Information content can be calculated in any study for which
both the overall variability and the noise variability are
available. We present in Table 1 information content for
three detailed physiological studies conducted in research
environment where special attention was given to accuracy
[11–13]. For each row of this table, we calculated for each
patient the signal size (expressed as a variance) and the noise
size (expressed as a variance), and displayed the average
values across all patients. Each study had measurements at
more than one heart rate, or via more than one monitoring
technique, and so had more than one row. Where raw data of
multiple replicates were available to us [12], noise variance
was quantified directly. Where data of only a single replicate
were available [13], noise variance was defined as the dis-
persion (expressed as a variance) of raw data away from a
best-fit regression parabola between the observed measure-
ments and the AV delay. Where noise variance was pub-
lished graphically [11], it was read off the graph. Signal
variance was defined as the total observed variance of that
patient minus noise variance. Because the protocols differed
between studies, this table should not be used to compare
optimization technologies, but rather just to obtain an idea of
the realistic range of information content achievable. It
Notional 
underlying pattern
Relatively low noise   Relatively high noise     
Noise
Observed 
data
+
=
Fig. 2 Observed measurements
are composed of underlying true
difference between settings
(‘‘signal’’, top panel) and beat-
to-beat variability (‘‘noise’’,
middle panel) which may be
small (left) or large (right)
relative to the signal. The
relative sizes of underlying
signal and overlying noise
determine whether the observed
measurements (bottom panel)
reflect the underlying signal
faithfully (left) or not (right).
When the noise variability is
relatively large (right), the
observed optimum (arrow) is
often not the true optimum
(140 ms in all cases in this
figure)
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should be remembered that these were conducted in ideal
research environments when there was effectively no time
pressure. Routine clinical practice, because of time pressure,
typically falls short of such ideal protocols that might require
as many as 1,500 beats to be acquired and analysed [14].
In this study, we present a simple way to establish the
impact of spontaneous beat-to-beat variability, by simu-
lating an optimization in which there is a known
underlying optimum setting at which cardiac function is
best, and alternative settings at which cardiac function
decays away. In the simulation, we can then superimpose
random variability simulating clinical beat-to-beat vari-
ability (the ‘‘noise’’). This simulation gives information
whose applicability is completely general across any
method of optimization that is based on selecting the
settings which gives the most favourable value of a
cardiovascular measure.
We aimed to determine
• how reliable optimization is
• how one can quantify the confidence interval of any
observed optimum
• whether one should trust an apparent increment in
cardiac function
• whether the observation that optima change over time is
a good reason to increase the frequency of repeat
optimization, and finally
• whether there are any straightforward steps we can take
to improve the quality of the optimization process.
Methods
Observed measurement = underlying
signal ? superimposed noise
We constructed a simulation to identify the impact of noise
variance, which is the random variability occurring
between one beat and another. This noise is superimposed
on the signal, which is the ‘‘true’’ underlying effect of the
pacemaker setting changes in real patient data. In clinical
practice, signal and noise cannot be separated in individual
raw data points because each such observed measurement
contains both contributions mixed together (however, if
replicate measurements are made, their inter-replicate
variance can be subtracted from the total variance of the
observed raw data to reveal the signal variance).
Simulation
In keeping with real patient data [15], the underlying signal
in our model was constructed as an inverted parabola with its
peak—the underlying optimum—at 140 ms. The verticalT
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size of the parabola was scaled to have the desired signal
magnitude. The magnitude was defined as the average of the
squared deviation from the mean: this definition is compu-
tationally identical to that of variance. Separately, we pro-
grammed noise as normally distributed random values with
mean zero and variance as desired. The signal and noise
were added together to create the simulated observations.
This process was repeated separately for each simulated
patient. For each analysis in this study, 1,000 patients were
simulated.
We tested signal and noise sizes over a wide range, but
for clarity in this paper we have presented a limited number
of values, ensuring that the full spectrum of relative sizes
of signal magnitude and noise variance is encompassed.
Identification of optimum
We defined the optimal setting as the one which gave the
highest measurement of cardiac function [3, 7, 16].
Because of the presence of noise, the measured value of
this optimum may not be the same as the underlying
optimum. The measured hemodynamic parameter is not
specified, but it could represent VTI [3], blood pressure or
dP/dt. The measurement is expressed without physical
units, for simplicity and generality. Because signal and
noise always will have the same unit, the choice of the unit
has no impact on reliability of optimization.
Confidence intervals of the optimum
We simulated repeat optimizations within the same indi-
vidual and collected the resulting optima in order to see
how widely these optima were scattered. We defined the
95% confidence interval of a single optimization as 1.96 9
the standard deviation of this collection of observed
optima. This is the confidence interval that would be
appropriate to report for each patient’s individual optimi-
zation, although by this method it is of course necessary to
carry out several optimizations per patient in order to
calculate the confidence interval.
Results
Impact of information content on consistency
of detecting optimum, using a single beat at each setting
With signal and noise both configured to be the same size,
the underlying curved shape of the signal was not always
evident in the observed measurements (signal ? noise).
Nevertheless inevitably, in each run, one of the settings
yielded the highest measurement and was duly selected as
the observed ‘‘optimum’’. Since this was not always the
true underlying optimum, the observed optima showed
some scatter (as shown schematically in Fig. 2).
For each combination of signal and noise size, we
quantified the observed scatter of optimization as the
standard deviation of difference between the optima
obtained on two successive optimizations of the same
patient. We calculated the information content from the
known sizes of signal and noise.
When signal and noise were equal, there was an opti-
mization scatter (standard deviation) of 45 ms. Making the
signal magnitude small made the scatter of the observed
optimum wider. Making the signal larger made the scatter
of the observed optimum narrower (Fig. 3, Spearman rank
correlation coefficient q = 0.973, P = 0.021). When the
noise was made smaller, the scatter of the observed opti-
mum narrowed. When the noise was made larger, the
scatter of the observed optimum widened (Fig. 3,
q = 0.991, P = 0.0017).
The information content was the overwhelming deter-
minant of the scatter of optima (q = 0.979, P \ 0.001,
Fig. 3). In the worst case scenario, i.e. information content
near zero, the scatter of optimization was *80 ms, the
implied range, 60–220 ms, covers the full range of settings
over which the simulations are performed.
We can compare this to the expected behaviour of an
entirely worthless optimization method, which would be to
use no physiological information but simply to select one
of the settings (60, 100, 140, 180, 220 ms) at random and
announce it to be the optimum. From first principles, the
mean ‘‘optimum’’ expected from such an approach is
140 ms, and the expected variance (average square of
deviate from that mean) is simply (802 ? 402 ? 02 ?
402 ? 802)/5 = 3,200 ms2, giving an expected optimiza-
tion scatter (SD of difference, SDD) of H2 9 H3,200 =
80 ms. This forms an effective limit on how poorly
reproducible any optimization amongst these settings can
be: SDD can never be more than 80 ms, for this range of
tested settings.
Figure 3 shows that the information content needs to be
rather high before the scatter of optimization even comes
close to values that clinicians may consider acceptable.
Even to get the SDD of successive optima down to 25 ms,
for example, we need information content of 0.91, i.e.
signal-to-noise ratio of 10:1.
Size of confidence interval of the observed optimum
We calculated the size of the confidence interval of the
observed optimum for a range of possible signal and noise
size combinations (and therefore information content) as
shown in Table 2.
Heart Fail Rev (2011) 16:277–290 281
123
Impact of averaging multiple replicates
on reproducibility
We tested the impact of changing a clinic’s optimization
policy to making, not just a single measurement at each
pacemaker setting, but several raw replicates (3, 10, 30 or
100), with average of all those replicate raw measurements
in that patient being plotted and used to select that patient’s
optimum setting. This process improved the fidelity with
which the observed measurements reflected the underlying
physiological value.
Effectively, the absolute impact of noise was reduced.
For example, using averages of 3 replicate raw measure-
ments reduced effective noise variance to one-third
(Table 2). With this elevation of the signal-to-noise ratio,
the shape of the underlying signal was more faithfully
depicted in the observed measurements (Fig. 4, left pan-
els), and the true optimum more likely to be detected
(Fig. 4, right panels).
Apparent versus true size of improvement
on optimization
We measured the apparent size of the increase in the
measured variable upon optimization. To make the results
easy to interpret, we simulated patients to arrive in the
optimization clinic with a reference setting of 100 ms and
undergo an optimization procedure. In each case, the
underlying true optimum is 140 ms, but because of noise
variability, the setting selected as optimum may be this or
another setting.
We calculated several aspects. First, the proportion of
patients in whom the observed optimum was a correct
reflection of the underlying true optimal AV delay.
Second, we calculated by how much the observed
optimum appeared to be better than the reference state. In
reality, we also knew how much the underlying optimum
was better than the underlying reference state, and we
reported this value too, for comparison. This enabled us to
report the extent to which the apparent increase over- or
under-estimated the underlying benefit. It was always an
over-estimation, as shown in the column ‘‘Extent of Illu-
sion’’ in Table 3. The size of this illusion was strongly
determined by the information content, with lower infor-
mation contents leading to larger illusory improvements
(q = –0.975, P \ 0.001).
Third, we calculated the observed difference between
the ‘‘best’’ setting and ‘‘worst’’ setting. Because we knew
the underlying difference between the true best and worst,
we were able to report this too, for comparison. Again we
were thereby able to calculate the illusory element (Fig. 5).
Apparent change in optimum over time
We simulated repeating the optimization process after the
passage of time, keeping the underlying optimum the same
between sessions. We calculated whether the observed
optima seemed to change between sessions and by how
much.
For each signal and noise combination, we observed the
resulting distribution of differences between the optima
found at the 1st and 2nd optimization visits. Figure 4
shows these distributions which have information content
of 0.91, 0.50 and 0.09, respectively. Since the true
Signal magnitude 
kept constant at 1
Noise variance  
kept constant at 1
Fig. 3 Scatter between successive optima increases when noise
variance is increased (Top panel) and decreases when signal
magnitude is increased (Middle panel). Information content, encom-
passing the relative sizes of signal and noise, has a powerful effect on
the scatter between successive optima. The bottom panel shows the
effect of information content (the proportion of variance that arises
from signal) on the scatter between successive optima
282 Heart Fail Rev (2011) 16:277–290
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underlying optimum did not change between visits, all
changes in observed optimum were false. The proportion of
patients of patients giving this false apparent change in
optimum is shown by dark shading on the Fig. 6.
Low information content was strongly linked to the
likelihood of false-positive detection of change in optimum
(q = 0.975, P \ 0.001)
When signal and noise were of equal size (information
content *0.50) about two-thirds of the patients have spu-
rious apparent changes in optimum between visits. Even
when the signal-to-noise ratio was 10:1, giving an infor-
mation content of 0.91, still one-third of patients had
spurious apparent changes in optimum. Only when signal-
to-noise ratio reached 30:1 (information content *0.97),
did the proportion of patients getting false-positive appar-
ent change in optima fall to a clinically respectable 7% (top
panel, Fig. 6).
Discussion
In this study, we have shown that uncritically selecting the
pacemaker setting which gives the best value of a moni-
tored variable might be little better than random selection
amongst a set of AV settings. These findings are generally
applicable to any optimization method that relies on testing
a series of settings whilst monitoring some measure of
cardiac function (such as echocardiographic velocity–time
integral or pressure or any other cardiovascular marker)
and then picking the setting that gives the highest
measurement.
It is overwhelmingly important for signal-to-noise ratio
(information content) to be high, otherwise a series of
illusions automatically arise in any clinical data analysis.
Illusion 1: ‘‘We have selected the true underlying
optima’’
One tends to assume that the setting which gives the
highest measurement is the best. However, our study shows
that only a very small amount of variability is enough to
seriously compromise this assumption because the true
biological effect may also be very small. With signal and
noise of equal size for example, in *50% of cases (Fig. 6)
the optimum detected will not be the true optimum but an
erroneous alternative.
The confidence interval of a clinical optimization is
never reported and (surprisingly) rarely asked for. A wide
confidence interval will have immediate comprehensibility
to any clinician reviewing the result. The simplest way to
calculate the confidence interval of optimization is to carry
it out on several occasions (e.g. immediately, one after the
other) and calculate the standard deviation. The 95% CI
would be the mean ± 1.96 9 standard deviation. To make
this reasonably valid, we would need to perform at least
three or four optimizations. Of course this would be
Table 2 Effect of signal and noise on the information content and on widths of 95% confidence limits
Properties of isolated
measurements
Effective properties of averaged replicate measurements Size of 95% confidence
interval of an observed
optimum
Signal
magnitude
Noise
variance
Information
content
Number of replicate
measurements
Effective noise
variance
Effective information
content
Scatter of optima,
SDD (ms)
1 1 0.50 1 1.00 0.50 45 ±62
1 1 0.50 3 0.33 0.75 37 ±51
1 1 0.50 10 0.10 0.91 24 ±33
1 1 0.50 30 0.03 0.97 12 ±16
1 1 0.50 100 0.01 0.99 0 ±0
1 10 0.09 1 1.00 0.50 66 ±91
1 10 0.09 3 0.33 0.75 58 ±80
1 10 0.09 10 0.10 0.91 42 ±58
1 10 0.09 30 0.03 0.97 35 ±49
1 10 0.09 100 0.01 0.99 26 ±36
1 100 0.01 1 1.00 0.50 74 ±103
1 100 0.01 3 0.33 0.75 74 ±102
1 100 0.01 10 0.10 0.91 68 ±94
1 100 0.01 30 0.03 0.97 57 ±79
1 100 0.01 100 0.01 0.99 43 ±60
For simplicity, the confidence intervals are shown centred on the ‘‘true’’ value. Greater information content gives narrower confidence intervals.
The effect of averaging multiple replicate measurements is to reduce the effective noise and therefore narrow the confidence interval
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100 measurements 
1 measurement 
10 measurements 
Fig. 4 Impact of switching
from single measurements to
average of multiple
measurements for the
optimization process. For
simplicity of presentation, the
simulated patients all have the
same underlying optimum
(140 ms), and the signal
magnitude and the noise
variance for a single measure is
set to be 1. The top panel
simulates optimization with a
single measurement made per
setting per patient. The lower
two panels simulate multiple
measurements made for each
setting in each patient, each
patient’s optimum being
determined using the averages
of that patient’s replicate
measurements. We display
detailed optimization curves in
10 example patients (left) and
the overall distribution of the
observed optimum in 1,000
patients (right).
Table 3 Impact of information content on the size of the apparent benefit of optimization
Signal
magnitude
Noise
variance
Information
content
Benefit from optimization: optimum minus worst Benefit from optimization: optimum minus reference
Apparent
measured
increase
True
underlying
illusion
Extent of
illusion (%)
Apparent
measured
increase
True
underlying
increase
Extent of
illusion (%)
1 1 0.50 3.3 2.1 ?54 1.1 0.5 ?105
1 10 0.09 7.8 2.1 ?263 3.2 0.5 ?497
1 100 0.01 23.7 2.1 ?1,008 11.2 0.5 ?2,002
10 1 0.91 7.5 6.8 ?11 1.9 1.7 ?10
10 10 0.50 10.4 6.8 ?54 3.3 1.7 ?98
10 100 0.09 24.8 6.8 ?267 10.5 1.7 ?522
100 1 0.99 21.9 21.4 ?2 5.4 5.3 ?0
100 10 0.91 23.6 21.4 ?10 5.6 5.3 ?6
100 100 0.50 32.9 21.4 ?54 11.2 5.3 ?110
For each combination of signal and noise variance, we show the apparent benefit of optimization (calculated from the measured data including
noise) and the true benefit (calculated from the underlying benefit with no noise). The illusory element is also shown, defined as the degree to
which the apparent measured increase overstates the true increase
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extremely time-consuming and is therefore not realistic
for routine clinical practice with current monitoring
techniques.
Alternatively one can determine information content of
the clinic’s optimization process in general. This could be
calculated once and then applied to all similar patients
without having to carry out multiple replicate optimizations
in each new clinical patient. Fortunately, information
content is easy to calculate: it is essentially the intraclass
correlation coefficient. This can be calculated quickly for a
representative group of patients by any laboratory. This is
similar, in principle, to using concepts of statistical power
analysis to routine clinical practice.
Illusion 2: ‘‘The optimization increased flow
(or pressure) by X and was therefore worthwhile’’
It is tempting to average the apparent increments in
velocity–time integral (or whatever measure was used for
optimization) achieved in an optimization service, and
Fig. 5 Relation between variability and apparent benefit of optimi-
zation. The presence of noise on its own does not consistently inflate
the apparent difference between two predetermined settings, since the
noise effect is sometimes positive and sometimes negative. However,
it can inflate the difference between a predetermined setting and the
apparently best setting. When there is sufficient noise to cause a
setting which is not the underlying optimum to appear to be the
optimum (because it happens to have had a positive noise element),
then we are effectively selecting the setting whose noise is most
positive. This introduces a consistent, positive bias whose size
increases as the noise becomes more dominant because the most
positive noise element is larger, and because in noisier environments
there is a larger group of settings amongst which the apparent
optimum might plausibly be drawn. As a result, larger noise
consistently inflates the difference between the apparent optimum
and any reference setting. Likewise the difference between maximum
and minimum is also artefactually inflated by increases in noise.
Apparent change in optimum from 1 to 2ndvisit (ms)st
Apparent change in optimum from 1 to 2ndvisit (ms)st
Apparent change in optimum from 1 to 2ndvisit (ms)st
78%
65%
31%
Fig. 6 Impact of information content on the probability of falsely
detecting a change in optimum. A group of patients is simulated
attending the optimization clinic twice, with their underlying optima
truly unchanged between visits. We calculate the apparent change in
optimum between visit 1 and visit 2. The table shows the percentage
who have a spurious apparent change depending on the information
content. Graphically we can see that when information content is high
(top panel) only 33% of patients have a spurious apparent change in
optimum. When information content is slower (middle and bottom
panels), the proportion of patient having a spurious apparent change
in optimum becomes much higher. It should be noted that simply
randomly choosing between five settings, gives an 80% (4/5) rate of
spurious detection of change in optimum, which is no worse than the
bottom panel.
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believe that first, (a) the process is almost always
increasing stoke volume, (b) the size of the average
increase in stroke volume is ‘X’ which sounds clinically
worthwhile and (c) since the increment is statistically sig-
nificant it is not likely to be a chance finding.
This study reveals all three of these tempting conclu-
sions to be wrong. First, the setting selected as apparently
optimum will always have a higher measured cardiac
function than the reference setting (except where the ref-
erence setting happens to be selected as the optimum).
Even if an optimization method was just roulette amongst
n tested settings, then in (n-1)/n cases (i.e. almost always)
it would be selecting an optimum different from reference.
Therefore, the statement that stroke volume is higher on the
optimal setting is meaningless.
Second, ironically, the worse the optimization method,
the larger the illusionary increase in stroke volume.
Third, unless carefully constructed [8], the statistical test
is assessing whether changes in stroke volume are ran-
domly distributed (some positive, some negative) with a
mean of zero. But each patient’s increment will always be
either positive or zero (never negative), so the average
increment will always be statistically significantly positive
unless the sample size is very small. Indeed, the worse the
optimization method, the more likely the apparent incre-
ment is to be statistically significantly positive.
Illusion 3: ‘‘The optimum has changed
between X months and now’’
A well-established and indispensable optimization clinic
may start to consider how often these optimizations should
be carried out [7, 9]. Is the contrast between patients’
optima on subsequent visits a useful guide? Our analyses
now show that if a technology has poor information content
(low signal-to-noise ratio), reproducibility will be poor. For
example, when signal and noise are approximately equal
(information content = 0.5) at 6 months (or any other
time), the optimum will falsely appear to have changed,
purely through noise, 65% of the time (Table 4). Ironically,
the worse the optimization process, the more the data
will seem to encourage more frequent optimizations. The
giveaway clue to this would be that however frequently we
re-optimize, there would still be a similar proportion who
would seem to need a change in setting.
Table 4 The number of
replicates required when
optimization is performed to
reduce the scatter of AV optima
obtained to a range of
acceptable confidence intervals
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Illusion 4: ‘‘We should not waste time making multiple
replicate measurements at each setting in clinical
practice’’
In a busy clinical department, it may seem an unnecessary
multiplication of work to make more than one measure-
ment at each setting. Instead, it may seem rational to
concentrate on ensuring that each measurement is acquired
and analysed properly by well-trained staff. Unfortunately,
the reasons for beat-to-beat variability in measurement are
many, and inadequate skill on the part of the sonographer
or interpreter is typically not the dominant contribution.
Rather, there is substantial beat-to-beat variability in
transvalvular blood flow, ventricular volumes, arterial
blood pressure and dP/dt. These variations may be due to
respiration and numerous other less-easily monitored
physiological processes that take place over periods of
seconds and minutes. They will not disappear through
wishful thinking alone. Instead, averaging multiple repli-
cate acquisitions gives us a powerful method to reduce the
effective noise. Effective noise (the variance of the aver-
aged value from R replicate raw measurements) falls in
direct proportion to 1/R, providing a simple way to
improve the information content. Another strategy is to
elevate heart rate, since this increases the size of the
signal [12].
Illusion 5: ‘‘We should optimize using whatever
measurement method we are most familiar with’’
Inter- and intra-observer variability may not be the domi-
nant source of noise, rather there may well be genuine
biological variation between beats. Even with excellent
clinical acquisition and measurement technique, if the
biological variability is large in comparison with the true
signal between settings, information content will be low.
We should quantify information content directly and not
assume that the technique with which we are most familiar
has a high information content.
Illusion 6: ‘‘Between separate beats, variability in my
laboratory is only X%, therefore this measure is suitable
for use in optimization’’
That X%, being the ratio between variability and mean
measurement, is not the relevant ratio for quality of opti-
mization. Reliability of optimization depends on the ratio
between beat-to-beat variability (noise) and between-set-
ting variability (signal). The ratio is much less favourable
than X%. For example, a VTI measurement might have a
mean value of 10 cm and a standard deviation of 1 cm,
giving a coefficient variance of 10%. However, the relevant
signal is not 10 cm but the standard deviation between
settings which may only be (for example) 1 cm. In this
case, the information content would be 1
1þ1 ¼ 0:5. The
naive figure of 10% variability, in isolation, is of no
relevance.
A simple method of calculating information content
of a cardiovascular measure used clinically
for optimization
Because this study was carried out using computer simu-
lation, it was possible to know the size of the true under-
lying signal, as well as the size of the noise, and thereby
state the information content directly.
In vivo, one can calculate information content by mea-
suring total variance and noise variance, since although the
underlying signal magnitude cannot be directly observed, it
is the difference between them. We need to carry out
several optimizations in the same patients. Suppose one
carries out R replicate sets of optimizations in one patient.
First, calculate the variance of all the raw measurements
(Vraw). Then one can calculate the mean measurement at
each pacemaker setting and then the variance (Vm) of these
means. Vm will tend to be smaller than Vraw, because the
impact of noise is reduced by the averaging process. The
lower the information content in the measurement, the
larger its noise in comparison with its signal, and therefore
the more markedly Vm will differ from Vraw. In brief, the
information content is approximately the ratio Vm/Vraw,
when K is large. More elaborately, accommodating for
R not always being large,
Information content ¼ R
R 1
Vm
Vraw
 1
R 1 ð2Þ
An example of how to calculate information content in a
single patient, using only standard spreadsheet software, is
shown in Fig. 7.
In practice, the examples of published data on infor-
mation content in Table 1 show that even with time-con-
suming methodology, including a high number of
replicates and many beats measured per replicate, infor-
mation content can still be low.
How many replicates are really needed in clinical
practice?
Clinicians cannot afford to waste time in clinical practice
on performing unnecessary numerous measurements dur-
ing optimization. Nor, though, can they waste time per-
forming apparent optimizations that they should know will
be worthless before the patient even lies down on the
couch. To choose rationally the number of replicates to
perform, it is vital to decide how precisely the patient’s
optimum needs to be identified.
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In clinical practice, each individual physician can decide
what level of precision is suitable in their context and can
easily calculate the number of replicates required to
achieve this as long as the information content of a single
replicate of their local method is known. The number of
replicates required for a range of such combinations is
shown in Table 4.
For example, a clinician may wish to know the AV
optimum with a 95% confidence interval of ±10 ms. How
many replicates are needed depends on the heart rate at
which optimization is to be carried out (Table 1). Studies at
resting heart rate have found rather low information con-
tents around 0.3.
If a confidence interval of optimization of ±10 ms is
wanted in this context, from Table 4 it can be seen that the
number of replicates needing to be conducted at each set-
ting is 59.
At higher heart rates such as 90 bpm, information
content is approximately 0.5–0.7 for several methods
Fig. 7 Calculation of information content using raw clinical data
from a single patient. In this example of real-life data from one
patient, four replicates of measurements at five settings are entered
into a table (columns E to H), and the mean at each setting calculated
(column K). The variance of the raw data is calculated (Cell H21)
using the formula shown immediately below it; the same is done for
the variance of the means (Cell K21). Information content is
calculated in cell K26 using the formula shown immediately below
it. The formulae shown are in appropriate form for standard
spreadsheet software such as OpenOffice or Microsoft Excel. In
particular, information content for several early patients (who would
need to undergo replicate measurements) can be averaged to allow the
laboratory to calculate typical confidence intervals to be reported
alongside optimal settings in future patients.
Fig. 8 The effect of heart rate on information content from datasets
of published studies regardless of method used for AV optimization
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(Table 1). Achieving a confidence interval of ±10 ms now
only requires 11–25 replicates, as shown in Table 4, which
might be achievable. At higher heart rates still, the number
of replicates needed continues to fall (Fig. 8).
Adjustment of VV delay, in contrast, exerts a much
smaller signal effect on physiological measurements than
AV adjustment by a factor of about 5–7 fold [15]. Even if
the variation in blood pressure is just fivefold smaller, the
information content is roughly 25-fold smaller—because it
is the variances (squared deviates) that matter. Therefore,
even assuming a favourably elevated (90 bpm) heart rate, a
favourable range of AV optimization information contents
of 0.5–0.7, and a possible relative signal variance for VV of
(1/7)2 to (1/5)2, the information content for VV would lie
between 0.01 and 0.03. It can be seen from Table 4 that
this necessitates well over 500 replicates at each setting to
achieve the desired precision of optimization.
Although there are detailed descriptions of meticulous
protocols [14] even putting together 1,500 beats of data does
not give high information content. Multi beat averages
reduce noise, but if signal is small, information content may
still be small. High heart rate raises signal magnitude [12]
and has allowed a higher information content to be obtained.
Clinical implications
No clinical optimization protocol currently specifies a
number of replicates to be carried out, whilst giving a
quantitative reasoning. This may be because the impact of
noise has not been considered or measured. It may not be
rational to conduct an optimization without ensuring ade-
quate precision of the optimum. Although there may be a
clinical imperative to be seen to be doing something, we
should not necessarily give in to perceived pressure to con-
duct a placebo procedure. Worse still, if the apparent opti-
mization is in fact no different to randomization amongst a
constrained range, it is inescapable that half of all such
procedures worsen cardiac efficiency rather than improve it.
If we want our optimization service to be delivering
clinical valuable results, there are three generic steps we
should take. First, we should have as large an underlying
signal as possible. For blood pressure changes, it has been
reported that the signal is larger in absolute terms at higher
heart rates than at lower heart rates [12].
Second, we should have as small a noise as possible. We
should not criticise operators for inadequate care when they
may simply be correctly measuring biological variability.
Instead we should design our measured variable and pro-
tocol to have a high information content.
Third, we can take averages of multiple replicate mea-
surements of cardiac function at each AV delay setting. An
R-fold replication will have the same beneficial effect as
reducing the noise variance of individual measurements by
R-fold. This can be applied to any measurement technique,
but of course carries the cost of increased labour.
Realization of these inherent properties of optimization
should encourage us to mandatorily report the noise and
information content of our monitored variable in our hands.
We should be able to therefore present the confidence
interval with every optimization we carry out. This may be
uncomfortable.
We emphasize that in this article we are not recom-
mending one method of measurement (e.g. VTI or pres-
sure) over another, nor suggesting whether measurement
should be invasive or non-invasive. The choice of mea-
surement modality for optimization should be prejudged by
personal preference or based on whim, but rather selected
on the balance of relevant properties. The most important
property of optimization (a process that recommends small
adjustments to pacemaker settings) is the precision with
which the recommendation is given. This is a neutral
article which simply provides a language to rationally
evaluate, discuss and improve this precision.
Practical recommendations
This analysis is completely general to all optimization
schemes which test a range of settings and select the one
with the greatest measurement. Any laboratory conducting
optimization can use Eq. 2 and Fig. 8 to calculate their
typical information content. In concert with device physi-
cians, who can recommend an acceptable confidence inter-
val, the laboratory can see how many replicates are required.
Such an estimated number of replicates required only
applies to an ‘‘average’’ patient in the population. The size
of the signal may vary between patients. For example, one
patient may have a particularly critical dependency on AV
setting and another a below-average amount of depen-
dency. The former would need fewer replicates to identify
the optimum within a given size of confidence interval, and
the later would need more. Similarly, one patient may have
more noise for one of many reasons, including deeper
respiration due to acute physiological distress; chronic lung
disease that enhances ventilatory fluctuation in haemody-
namics; obesity impairing image quality; agitation
impairing probe position maintenance. This would neces-
sitate more replicates.
But whilst individual patients may have different strict
needs for replication, all patients will need more replicates
if the optimization technique has poor information content.
Any protocol document (which specifies and optimization
technique) to be credible must at least give quantitatively
sound guidance as to the number of replicates needed for
an average patient to obtain optimization with a level of
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precision widely considered reasonable. If a protocol does
not give such guidance, clinical time pressures may lead to
all patients having optimizations that are, on average,
worthless (helping half slightly and harming half slightly).
Conclusions
Information content, the proportion of the observed dif-
ferences in the measurements at different settings that is
genuinely due to the change in settings, has an over-
whelmingly important impact on the meaningfulness of
the pacemaker optimization processes. Although easy to
measure, it is rarely reported or commented on, and may be
surprisingly low unless steps are taken to improve it.
Low information content leads to frequent misidentifi-
cation of the optimum. However, worse than this, it inflates
the apparent benefit of optimization: counter-intuitively, the
worse the optimization method, the better it will superficially
appear (unless one asks about information content).
Worst of all, because low information content makes
apparent optima more variable, the poorer the optimization
method, the more frequently one will feel compelled to re-
optimize the patient (unless we ask about information content).
Information content is easy to improve for any tech-
nique. All that is needed is (a) to use a technique where the
underlying difference between settings is as large as pos-
sible, (b) to use a technique with beat-to-beat variability as
small as possible and (c) to make multiple measurements at
each setting and calculate the average.
If, despite these steps, information content is still low,
clinical resources could be saved by selecting a setting
arbitrarily or even at random, with no additional loss to the
patient’s physiology. We do not make this suggestion for
fun but to point out the seriousness of the present situation.
Optimization is not optimization when it is roulette.
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